Massively parallel in vivo CRISPR screening identifies RNF20/40 as epigenetic regulators of cardiomyocyte maturation

The forward genetic screen is a powerful, unbiased method to gain insights into biological processes, yet this approach has infrequently been used in vivo in mammals because of high resource demands. Here, we use in vivo somatic Cas9 mutagenesis to perform an in vivo forward genetic screen in mice t...

Descripción completa

Detalles Bibliográficos
Autores principales: VanDusen, Nathan J., Lee, Julianna Y., Gu, Weiliang, Butler, Catalina E., Sethi, Isha, Zheng, Yanjiang, King, Justin S., Zhou, Pingzhu, Suo, Shengbao, Guo, Yuxuan, Ma, Qing, Yuan, Guo-Cheng, Pu, William T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295283/
https://www.ncbi.nlm.nih.gov/pubmed/34290256
http://dx.doi.org/10.1038/s41467-021-24743-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295283/
https://www.ncbi.nlm.nih.gov/pubmed/34290256
http://dx.doi.org/10.1038/s41467-021-24743-z

Ejemplares similares